StonvexLoading…
StonvexStonvexStonvexCore line items from BRSL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.51B | $2.51B | $2.53B | $2.60B |
Operating Income | $299.00M | $686.00M | $752.00M | $743.00M |
Net Income | $147.00M | $348.00M | $156.00M | $275.00M |
EPS (Diluted) | $0.74 | $1.71 | $0.77 | $1.35 |
Total Assets | $9.16B | $10.28B | $10.46B | $10.43B |
Total Liabilities | $7.57B | $8.22B | $8.51B | $8.45B |
Cash & Equivalents | $1.45B | $584.00M | $508.00M | $590.00M |
Free Cash Flow OCF − CapEx | $-415.00M | $901.00M | $865.00M | $737.00M |
Shares Outstanding | 186.85M | 201.86M | 200.48M | 199.08M |